With 1 ETF traded in the U.S. markets, Dynamic Biotechnology & Genome Intellidex Index ETF gathers total assets under management of $248.05M. The average expense ratio is 0.59%. Dynamic Biotechnology & Genome Intellidex Index ETF can be found in the following asset class:
See the top-performing biotech ETFs and the potential benefits of investing.
It's still early in the year, but a number of ETFs have already lost 25-50% of their value in 2016.
A look at which ‘smart beta’ funds are top and bottom performers so far this year.
A look at which ‘smart beta’ funds are top and bottom performers so far this year.
One market expert suggests it may be time for share splits in the largest ETFs.
So far in 2014, India, coffee, biotech and long-dated Treasurys have been good to investors.
Biotech ETFs are defying predictions that small-cap stocks are likely to be under pressure.
Looking under the hood of any fund you own can prevent a lot of surprises.
The latest tally of year-to-date top-10-performing ETFs include Japan, clean energy and biotech funds, to name a few.